Fornebu, July 3, 2024 - Aker BioMarine ASA ("Aker BioMarine") today announced
that it has entered into an agreement with American Industrial Partners ("AIP")
and Aker Capital ("Aker") for the sale of Aker BioMarine's ownership position in
the Feed Ingredients business, based on an enterprise valuation of USD 590
million (around NOK 6.3 billion). The acquiring party will be a newly
established company owned 60% by AIP and 40% by Aker Capital.

On 14 February 2024, Aker BioMarine announced a strategic review of its
ownership position in the Feed Ingredients business. The transaction will create
significant shareholder value and is an important step in crystallizing value
and enables a focused Aker BioMarine within the human health and nutrition
business. 

"We are pleased to announce the sale of our ownership position in the Feed
Ingredients business. This transaction is the result of a process that attracted
interest from a wide range of reputable parties and not only demonstrates the
value of Feed Ingredients but also underscores the value potential of Aker
BioMarine as a whole. We will continue to explore how we can drive shareholder
value by enabling potential partnerships and transactions for each of the
remaining business units", says Matts Johansen, CEO of Aker BioMarine.

The enterprise value of USD 590 million (on a cash and debt-free basis), is to
be adjusted for normalized working capital and excess product inventory at
closing. Upon closing of the transaction, Aker BioMarine intends to refinance
its debt to obtain an appropriate leverage for the remaining business, and
targets to distribute an extraordinary dividend after closing. Management
expects the proposed dividend to be between NOK 35 and NOK 45 per share. Further
details will be communicated in connection with closing of the transaction.

Following the transaction, Aker BioMarine will be a focused human health and
nutrition company consisting of three business units